Share on StockTwits
 

UBS AG started coverage on shares of Bayer AG (NASDAQ:BAYRY) in a research note issued on Thursday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating on the stock.

Several other analysts have also recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Bayer AG in a research note to investors on Friday, December 27th. They now have a $147.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $147.00.

Bayer AG is a German management holding company with core competencies in the field of health care, nutrition and high-tech materials.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.